Cargando…
Evaluation of drug-targetable genes by defining modes of abnormality in gene expression
In the post-genomic era, many researchers have taken a systematic approach to identifying abnormal genes associated with various diseases. However, the gold standard has not been established, and most of these abnormalities are difficult to be rehabilitated in real clinical settings. In addition to...
Autores principales: | Park, Junseong, Lee, Jungsul, Choi, Chulhee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559746/ https://www.ncbi.nlm.nih.gov/pubmed/26336805 http://dx.doi.org/10.1038/srep13576 |
Ejemplares similares
-
Identification of phenotype deterministic genes using systemic analysis of transcriptional response
por: Lee, Jungsul, et al.
Publicado: (2014) -
Constitutive Expression of MAP Kinase Phosphatase-1 Confers Multi-drug Resistance in Human Glioblastoma Cells
por: Yu, Hana, et al.
Publicado: (2012) -
Mitochondrial Network Determines Intracellular ROS Dynamics and Sensitivity to Oxidative Stress through Switching Inter-Mitochondrial Messengers
por: Park, Junseong, et al.
Publicado: (2011) -
Robust method for identification of prognostic gene signatures from gene expression profiles
por: Sim, Woogwang, et al.
Publicado: (2017) -
Mutant Ubiquitin Attenuates Interleukin-1β- and Tumor Necrosis Factor-α-Induced Pro-Inflammatory Signaling in Human Astrocytic Cells
por: Choi, Kyungsun, et al.
Publicado: (2013)